A Medicare contractor last week said it would not cover the CardioMEMS implantable heart monitor made by St. Jude Medical (NYSE:STJ), citing the need for more clinical data on the device. Novitas, a Medicare Administrative Contractor that covers patients in Pennsylvania, New Jersey, Maryland, Delaware, Colorado, Oklahoma, New Mexico, Texas, Arkansas, Louisiana, Mississippi and and Washington, D.C., said it […]
BrainScope wrangles up new C-suite | Personnel Moves
Brainscope today announced a number of new assignments to its executive roster, assigning 4 new picks to its c-suite. The Bethesda, Ma.-based neurotech company picked up Dr. Leslie Prichep as chief scientific officer, Kerstin Schultz as president and COO, Angad Singh as chief technology officer, and promoted Laurie Silver to CFO. “These additions to our leadership team will help […]
Ishrak: ‘With COV We’ll do for ORs what we’ve done for cath labs’ | The week in medtech M&A
CardioMEMS, Nevro among top 20 VC-backed healthcare exits of 2014
At least 4 medtech exits were significant enough to make the cut for the top 20 venture capital-backed healthcare exits of 2014, according to research firm CB Insights.
Study: St. Jude Medical’s CardioMEMS device slashes readmission rates
St. Jude Medical CEO: CardioMEMS the ‘single most important new growth driver’
Study: CardioMEMs implanted heart monitor safe for renal failure patients
St. Jude Medical (NYSE:STJ) subsidiary CardioMEMs touted new study results this week showing that its implanted heart monitor is safe and effective in patients with chronic kidney disease.
CardioMEMS’ 11-year payoff worth the wait for Boston Millennia Partners
The CardioMEMS story didn’t end when St. Jude Medical (NYSE:STJ) acquired the Georgia-based company in June, paying $375 million for the stake it didn’t already own, valuing the implantable heart failure monitor company at $463 million total.
St. Jude Medical closes $455M CardioMEMS buy
St. Jude Medical (NYSE:STJ) wasted no time in closing its acquisition of CardioMEMS, days after the FDA approved the Champion HF implantable heart monitor, saying it plans to begin a "strategic" launch of the device in the U.S.
CardioMEMS wins FDA approval for its 1st implantable heart monitor, St. Jude goes for the buy
